Silexion Therapeutics
SLXN · NASDAQ
$0.1538+$0.0008 (+0.52%)TodayMarket closed ·
Prev close $0.153
Who owns SLXN
Largest institutional holders, from their latest 13F filings
| Holder | Shares | % of shares |
|---|---|---|
| Moringa Sponsor LP | 1.39M | 131.30% |
| Intracoastal Capital, L.L.C. | 128.92K | 12.16% |
| Hadar (Ilan) | 16.55K | 1.56% |
| HRT Financial LP | 15.24K | 1.44% |
| Lincoln Alternative Strategies LLC | 13.13K | 1.24% |
| Horenshtein (Hadar Mirit) | 12.47K | 1.18% |
| Orca Capital GmbH | 10.94K | 1.03% |
| Shirvan (Mitchell) | 8.06K | 0.76% |
| Heights Capital Management, Inc. | 3.04K | 0.29% |
| Guangzhou Sino-Israel Biotech Fund | 2.73K | 0.26% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of SLXN in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Horenshtein Hadar Mirit | Award | 7.50K | — |
| Shirvan Mitchell | Award | 6.00K | — |
| Hadar Ilan | Award | 10.00K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 4.93M
- Days to cover
- 1.00
- % of shares outstanding
- 464.71%
- Average daily volume
- 40.44M
- Change since last report
- +1964.4%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.